Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016 (2016), Article ID 8315454, 9 pages
http://dx.doi.org/10.1155/2016/8315454
Research Article

Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver

1Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 600 Yishan Road, Shanghai 200233, China
2Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 600 Yishan Road, Shanghai 200233, China
3Shanghai Key Laboratory of Diabetes Mellitus, 600 Yishan Road, Shanghai 200233, China
4Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 600 Yishan Road, Shanghai 200233, China

Received 6 November 2014; Revised 2 June 2015; Accepted 1 July 2015

Academic Editor: Afshan Malik

Copyright © 2016 Yun-Xia Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplemental materials includes one table and one figure in which present clinical background data of human liver samples (Table S1) and protein expression of hepatic LSDP5 in mice (Figure S1), respectively.

Supplementary Figure S1. LSDP5 protein expression in mouse liver. Immunoblot analyses of LSDP5 protein expression in liver from mice fed with a chow or high-fat diet (HF) for 20 weeks, and from db/db mice. M: mouse muscle, positive control for LSDP5 expression.

  1. Supplementary Material